title: Involvement of OX40 ligand+ mast cells in chronic GVHD after allogeneic hematopoietic stem cell transplantation.
authors.forename: A
authors.initials: A
authors.lastname: Kotani
authors.forename: T
authors.initials: T
authors.lastname: Hori
authors.forename: T
authors.initials: T
authors.lastname: Fujita
authors.forename: N
authors.initials: N
authors.lastname: Kambe
authors.forename: Y
authors.initials: Y
authors.lastname: Matsumura
authors.forename: T
authors.initials: T
authors.lastname: Ishikawa
authors.forename: Y
authors.initials: Y
authors.lastname: Miyachi
authors.forename: K
authors.initials: K
authors.lastname: Nagai
authors.forename: Y
authors.initials: Y
authors.lastname: Tanaka
authors.forename: T
authors.initials: T
authors.lastname: Uchiyama
mesh_terms: D000293:Adolescent; D000328:Adult; D000943:Antigens, Differentiation / Q000276:immunology*; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D008297:Male; D008407:Mast Cells / Q000276:immunology*; D008875:Middle Aged; D053278:OX40 Ligand / Q000276:immunology*; D012867:Skin / Q000473:pathology; D014184:Transplantation, Homologous
chemical_list: D000943:Antigens, Differentiation; D053278:OX40 Ligand; C406562:OX40Ig; C089251:TNFSF4 protein, human